Bank of New York Mellon’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.95M Buy
207,702
+4,748
+2% +$44.7K ﹤0.01% 2758
2025
Q1
$1.1M Sell
202,954
-1,306
-0.6% -$7.08K ﹤0.01% 3000
2024
Q4
$1.52M Buy
204,260
+37,054
+22% +$276K ﹤0.01% 2876
2024
Q3
$1.34M Sell
167,206
-37,686
-18% -$301K ﹤0.01% 2971
2024
Q2
$1.78M Buy
204,892
+50,388
+33% +$438K ﹤0.01% 2855
2024
Q1
$3.19M Buy
154,504
+24,894
+19% +$515K ﹤0.01% 2527
2023
Q4
$3M Buy
129,610
+13,920
+12% +$322K ﹤0.01% 2625
2023
Q3
$924K Buy
115,690
+12,309
+12% +$98.3K ﹤0.01% 3198
2023
Q2
$899K Buy
103,381
+31,521
+44% +$274K ﹤0.01% 3256
2023
Q1
$211K Sell
71,860
-8,188
-10% -$24.1K ﹤0.01% 3896
2022
Q4
$280K Buy
80,048
+2,731
+4% +$9.56K ﹤0.01% 3824
2022
Q3
$612K Buy
77,317
+7,388
+11% +$58.5K ﹤0.01% 3466
2022
Q2
$550K Sell
69,929
-9,478
-12% -$74.5K ﹤0.01% 3530
2022
Q1
$966K Buy
79,407
+3,985
+5% +$48.5K ﹤0.01% 3338
2021
Q4
$923K Buy
75,422
+3,688
+5% +$45.1K ﹤0.01% 3427
2021
Q3
$747K Buy
71,734
+12,783
+22% +$133K ﹤0.01% 3567
2021
Q2
$530K Buy
+58,951
New +$530K ﹤0.01% 3741
2020
Q4
Sell
-2,718
Closed -$14K 4223
2020
Q3
$14K Hold
2,718
﹤0.01% 4094
2020
Q2
$21K Sell
2,718
-14,425
-84% -$111K ﹤0.01% 4049
2020
Q1
$175K Buy
17,143
+1,080
+7% +$11K ﹤0.01% 3770
2019
Q4
$249K Sell
16,063
-375
-2% -$5.81K ﹤0.01% 3853
2019
Q3
$297K Buy
16,438
+1,451
+10% +$26.2K ﹤0.01% 3775
2019
Q2
$245K Buy
14,987
+10,386
+226% +$170K ﹤0.01% 3862
2019
Q1
$82K Sell
4,601
-549
-11% -$9.78K ﹤0.01% 4026
2018
Q4
$97K Buy
5,150
+2,264
+78% +$42.6K ﹤0.01% 3958
2018
Q3
$103K Hold
2,886
﹤0.01% 4023
2018
Q2
$60K Sell
2,886
-682
-19% -$14.2K ﹤0.01% 4061
2018
Q1
$43K Buy
3,568
+679
+24% +$8.18K ﹤0.01% 4169
2017
Q4
$31K Buy
2,889
+3
+0.1% +$32 ﹤0.01% 4246
2017
Q3
$35K Hold
2,886
﹤0.01% 4163
2017
Q2
$49K Sell
2,886
-96
-3% -$1.63K ﹤0.01% 4133
2017
Q1
$52K Buy
2,982
+96
+3% +$1.67K ﹤0.01% 4125
2016
Q4
$49K Sell
2,886
-2,285
-44% -$38.8K ﹤0.01% 4130
2016
Q3
$156K Sell
5,171
-593
-10% -$17.9K ﹤0.01% 3945
2016
Q2
$163K Buy
5,764
+12
+0.2% +$339 ﹤0.01% 3949
2016
Q1
$154K Buy
5,752
+2,142
+59% +$57.3K ﹤0.01% 3859
2015
Q4
$174K Sell
3,610
-2,732
-43% -$132K ﹤0.01% 3886
2015
Q3
$231K Buy
6,342
+13
+0.2% +$474 ﹤0.01% 3814
2015
Q2
$239K Buy
6,329
+518
+9% +$19.6K ﹤0.01% 3841
2015
Q1
$229K Sell
5,811
-35
-0.6% -$1.38K ﹤0.01% 3862
2014
Q4
$240K Buy
5,846
+2,699
+86% +$111K ﹤0.01% 3839
2014
Q3
$139K Hold
3,147
﹤0.01% 3968
2014
Q2
$137K Buy
3,147
+6
+0.2% +$261 ﹤0.01% 3928
2014
Q1
$129K Buy
3,141
+405
+15% +$16.6K ﹤0.01% 3919
2013
Q4
$109K Sell
2,736
-141
-5% -$5.62K ﹤0.01% 3948
2013
Q3
$118K Buy
2,877
+96
+3% +$3.94K ﹤0.01% 3879
2013
Q2
$108K Buy
+2,781
New +$108K ﹤0.01% 3885